Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The baby must have epilepsy (seizures) that started before they were 1 month old and required starting anti-seizure medication.
- The epilepsy must not have a one-off or temporary cause (such as a blood sugar problem or infection).
- The epilepsy must not be explained by a structural problem or malformation in the brain.
- The parents or guardians must not object to their baby taking part in the trial.
- The parents or guardians must be able to fill in questionnaires about their baby.
Who may not be able to join:
- Babies whose seizures were caused by a short-term or one-off issue, such as a blood sugar disorder or an infection.
- Babies whose epilepsy developed as a result of brain damage from a lack of oxygen at birth or a stroke.
- Babies whose epilepsy is related to a structural abnormality or malformation of the brain.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jean Olivier Arnaud, Assistance Publique - Hôpitaux de Marseille
Phone: 0491322903
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
importance of the developmental disorder; definition of the active phase of epilepsy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.